EGFR and neoplasm: The impact of USP11 on EGFR signaling was validated using USP11-KO cells, which demonstrated reduced EGFR stability and in vivo tumorigenic effect, and diminished responses to EGF stimulation in migration, proliferation, and 3D tumor spheroid assays.